Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Jaeb Center for Health Research, Inc.
Tampa, Florida
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 40
| Name | Type | Company | Disclosed Value | Year Filed |
|---|---|---|---|---|
| Lloyd Aiello | Conflict of Interest | Kalvista | $500,000 - $549,999 | 2019 |
| Jay Stewart | Conflict of Interest | Roche | $100,000 - $149,999 | 2019 |
| Charles Wykoff | Conflict of Interest | Regeneron | $80,000 - $99,999 | 2019 |
| Dilsher Dhoot | Conflict of Interest | Regeneron | $80,000 - $99,999 | 2019 |
| Calvin Mein | Conflict of Interest | Novartis | $80,000 - $99,999 | 2019 |
| Lloyd Aiello | Conflict of Interest | Kalvista | $40,000 - $59,999 | 2019 |
| Brandon Lujan | Conflict of Interest | Genentech | $40,000 - $59,999 | 2019 |
| Yannek Leiderman | Conflict of Interest | Alcon | $40,000 - $59,999 | 2019 |
| Michael Elman | Conflict of Interest | Notal Vision | $40,000 - $59,999 | 2019 |
| David Kleinman | Conflict of Interest | ONL Therapeutics | $40,000 - $59,999 | 2019 |
| Dilsher Dhoot | Conflict of Interest | Alimera Sciences | $40,000 - $59,999 | 2019 |
| Rahul N. Khurana | Conflict of Interest | Genentech | $20,000 - $39,999 | 2018 |
| David Kleinman | Conflict of Interest | Notal Vision | $20,000 - $39,999 | 2019 |
| Dilsher Dhoot | Conflict of Interest | Genentech | $20,000 - $39,999 | 2019 |
| Michael Singer | Conflict of Interest | Allergan | $20,000 - $39,999 | 2019 |
| Jay Stewart | Conflict of Interest | Genentech | $20,000 - $39,999 | 2019 |
| Ivan Suner | Conflict of Interest | Genentech | $20,000 - $39,999 | 2019 |
| Michael Elman | Conflict of Interest | Notal Vision | $20,000 - $39,999 | 2019 |
| Lloyd Aiello | Conflict of Interest | Novo Nordisk | $20,000 - $39,999 | 2019 |
| Michael Singer | Conflict of Interest | Regeneron | $20,000 - $39,999 | 2019 |
| Veeral Sheth | Conflict of Interest | Genentech | $20,000 - $39,999 | 2019 |
| Rahul N. Khurana | Conflict of Interest | Regeneron | $20,000 - $39,999 | 2018 |
| Michael Singer | Conflict of Interest | Genentech | $20,000 - $39,999 | 2019 |
| John Pitcher III | Conflict of Interest | Genentech | $20,000 - $39,999 | 2019 |
| Patrick Ma | Conflict of Interest | Allergan | $10,000 - $19,999 | 2019 |
| Joseph M. Coney | Conflict of Interest | Genentech | $10,000 - $19,999 | 2018 |
| Jesse Jung | Conflict of Interest | Carl Zeiss | $10,000 - $19,999 | 2019 |
| Patrick Ma | Conflict of Interest | Allergan | $10,000 - $19,999 | 2019 |
| Jay Stewart | Conflict of Interest | Genentech | $10,000 - $19,999 | 2019 |
| Yannek Leiderman | Conflict of Interest | Alcon | $10,000 - $19,999 | 2019 |
| Jesse Jung | Conflict of Interest | Carl Zeiss | $10,000 - $19,999 | 2019 |
| Jay Stewart | Conflict of Interest | Genentech | $10,000 - $19,999 | 2019 |
| Aleksandra V. Rachitskaya | Conflict of Interest | Alcon | $5,000 - $9,999 | 2018 |
| Thomas M. Aaberg Jr. | Conflict of Interest | Alcon | $5,000 - $9,999 | 2019 |
| Joseph M. Coney | Conflict of Interest | Allergan | $5,000 - $9,999 | 2018 |
| Joseph M. Coney | Conflict of Interest | Alimera Sciences | $5,000 - $9,999 | 2018 |
| David Kleinman | Conflict of Interest | ONL Therapeutics | 2019 | |
| Ivan Suner | Conflict of Interest | Genentech | 2019 | |
| Charles Wykoff | Conflict of Interest | Regeneron | 2019 | |
| Michael Elman | Conflict of Interest | Notal Vision | 2019 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.